PTKF.F Stock Overview
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
PT Kalbe Farma Tbk. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | Rp0.09 |
52 Week High | Rp0.15 |
52 Week Low | Rp0.09 |
Beta | 0.19 |
1 Month Change | -9.18% |
3 Month Change | -12.15% |
1 Year Change | -36.58% |
3 Year Change | -10.00% |
5 Year Change | n/a |
Change since IPO | 28.57% |
Recent News & Updates
Recent updates
Shareholder Returns
PTKF.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | -0.2% | 0.6% |
1Y | -36.6% | 23.9% | 29.5% |
Return vs Industry: PTKF.F underperformed the US Pharmaceuticals industry which returned 23.9% over the past year.
Return vs Market: PTKF.F underperformed the US Market which returned 29.5% over the past year.
Price Volatility
PTKF.F volatility | |
---|---|
PTKF.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.5% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PTKF.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PTKF.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1966 | 13,134 | - Vidjongtius | https://www.kalbe.co.id |
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals and Distribution; and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products.
PT Kalbe Farma Tbk. Fundamentals Summary
PTKF.F fundamental statistics | |
---|---|
Market cap | US$4.41b |
Earnings (TTM) | US$187.44m |
Revenue (TTM) | US$1.92b |
23.5x
P/E Ratio2.3x
P/S RatioIs PTKF.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PTKF.F income statement (TTM) | |
---|---|
Revenue | Rp30.31t |
Cost of Revenue | Rp18.70t |
Gross Profit | Rp11.61t |
Other Expenses | Rp8.65t |
Earnings | Rp2.96t |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 64.03 |
Gross Margin | 38.31% |
Net Profit Margin | 9.77% |
Debt/Equity Ratio | 4.7% |
How did PTKF.F perform over the long term?
See historical performance and comparison